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Abstract
2Cerebral ischaemia, associated with neuroinflammation and oxidative stress, is known to
perturb blood-brain barrier (BBB) integrity and promote brain oedema formation. Using an in
vitro model of human BBB composed of brain microvascular endothelial cells and astrocytes,
this study examined whether suppression of TNF-α, a potent pro-inflammatory cytokine, might 
attenuate ischaemia-mediated cerebral barrier damage. Radical decreases in transendothelial
electrical resistance and concomitant increases in paracellular flux across co-cultures exposed
to increasing periods of oxygen-glucose deprivation alone (0.5-20 h) or followed by 20 h of
reperfusion (OGD±R) confirmed the deleterious effects of ischaemic injury on cerebral barrier
integrity and function which concurred with reductions in tight junction protein (claudin-5 and
occludin) expressions. OGD±R elevated TNF-α secretion, NADPH oxidase activity, O2.-
production, actin stress fibre formation, MMP-2/9 activities and apoptosis in both endothelial
cells and astrocytes. Increases in MMP-2 activity were confined to its extracellular isoform and
treatments with OGD+R in astrocytes where MMP-9 could not be detected at all. Co-exposure
of individual cell lines or co-cultures to an anti-TNF-α antibody dramatically diminished the 
extent of OGD±R-evoked oxidative stress, morphological changes, apoptosis, MMP-2/9
activities while improving the barrier function through upregulation of tight junction protein
expressions. In conclusion, vitiation of the exaggerated release of TNF-α may be an important 
therapeutic strategy in preserving cerebral integrity and function during and following a
cerebral ischaemic attack.
Keywords: TNF-α, ischaemic injury, cerebral barrier, in vitro model of BBB, NADPH
oxidase, MMP.
Introduction
3Ischaemic strokes emerging from an interference with blood supply to the central nervous
system are characterised by disruption of the blood-brain barrier (BBB) and ensuing formation
of brain oedema which constitute the leading cause of death within the first week after a stroke.
The BBB consists of brain microvascular endothelial cells (BMEC), capillary basement
membrane and astrocyte end-feet that control the exchange of molecules between the systemic
circulation and the brain (Ballabh et al., 2004; Hayashi et al., 2004). As the presence of tight
junctions (TJ), formed between adjacent endothelial cells via a series of intricate interactions
between actin cytoskeleton and the major transmembrane and associated cytoplasmic proteins
like claudin-5, occludin and zonula occludens-1, determines the overall BBB integrity and
function, all intrinsic, extrinsic or humoral pathologies capable of affecting the appropriate
construction of these junctional complexes will unavoidably affect the permeability of BBB
(Dejana, 2004; Farrall and Wardlaw, 2009; Sandoval and Witt, 2008). Post-ischaemic
neuroinflammation accompanied by exaggerated synthesis of pro-inflammatory cytokines has
long been considered a central feature in cerebral barrier dysfunction. Indeed, excessive release
of several cytokines, notably TNF-α by infiltrated leukocytes and resident microglia during
and/or after a cerebral attack is closely implicated in BBB breakdown through successive
inductions of the most potent pro-oxidant and basement membrane-degrading enzymes,
namely NADPH oxidase and matrix metalloproteinases (MMPs), respectively (Candelario-
Jalil et al., 2009; Gao et al., 2008; Yang et al., 1999).
Immediately after focal ischaemia, a series of events including oxidative stress characterised
by excessive availability of superoxide anion (O2.-) occur. Once generated, O2.- evokes
endothelial barrier failure in a direct fashion and through induction of BBB-related cell
apoptosis (Basuroy et al., 2006). Other than reoxygenation of ischaemic tissue during
reperfusion, activation of NADPH oxidase also significantly contributes to TNF-α-mediated 
overproduction of O2.- in vasculature (Chen et al., 2011; Gao et al., 2008; Zhang et al., 2006).
4NADPH oxidase is composed of several cytosolic subunits and two membrane-bound
components i.e. gp91-phox and p22-phox that are required for enzymatic activity and stability
as a whole. Recent evidence have shown that both endothelial cells and astrocytes express all
these subunits where efficacious suppression of oxidase activity via various structurally-
distinct inhibitors like apocynin or minocycline improves cerebrovascular integrity after
transient occlusion of middle cerebral artery by attenuating O2.- generation, endothelial
dysfunction, BBB breakdown and the volume of brain oedema (Abdullah and Bayraktutan,
2014; Chen et al., 2009; Kahles et al., 2007; Williams et al., 2010).
Ischaemia-evoked induction of MMPs which lead to dissolution of extracellular matrixand basement membrane may also contribute to TNF-α-evoked BBB damage (Muhs et al., 
2003; Parks et al., 2004). Aberrant endothelial cell anchoring and impaired matrix-endothelialcell signal transduction stemming from digestion of the structural support is likely toexacerbate the barrier damage. Indeed, a close correlation between TNF-α-evoked 
overexpression of MMP-2/9 and the extent of BBB openings has recently been shown in an
experimental setting of focal cerebral ischaemia (Gasche et al., 1999; Rosenberg et al., 1998).
In light of the above, this study investigated the specific role of TNF- in OGD±R-evoked
BBB dysfunction with particular regards to modulations of NADPH oxidase, TJ protein
expressions, MMP activity, cytoskeletal reorganisation and apoptosis using BMEC and
astrocytes simultaneously.
Materials and Methods
All chemicals used during this study were from Sigma (Dorset, UK) unless otherwise stated.
Cell culture
Human BMEC (HBMEC) and astrocytes (HA) were purchased from TCS CellWorks Ltd
(Buckingham, UK) and cultured in their respective specialised media (Sciencell Research
Laboratories, San Diego, USA) in a humidified atmosphere (75% N2, 20% O2, 5% CO2) at
537ºC. The EC media were supplemented with 5% foetal bovine serum, 1%
penicillin/streptomycin mix and 1% endothelial growth supplement while the astrocyte media
were supplemented with 2% foetal bovine serum, 1% penicillin/streptomycin mix and 1%
astrocyte growth supplement. In some experiments, cells cultured to ~90% confluence and
exposed to 4 h of OGD alone (94.95% N2, 0.05% O2, 5% CO2) or followed by 20 h of
reperfusion (OGD±R). All OGD experiments were performed using the D-glucose free
medium (RPMI 1640, Invitrogen) and an MCO-18M multi-gas incubator (Sanyo, UK) flushed
with N2. O2 levels were checked using an oxygen fyrite test kit (LEEC, UK) before use.
Reperfusion was initiated by returning cells to normoxic conditions after changing the OGD
media with the respective specialised media. In other experiments, the cells, in addition to
OGD±R, were also exposed to an anti-TNF-α antibody (R&D Systems, Abingdon, UK). The 
antibody was added to the cells at the beginning of OGD and reperfusion for OGD alone and
OG+R experiments, respectively.
Since both HBMEC and HA retain their BBB-specific properties at earlier passages, all the
outlined experiments were performed using cells cultured up to and including passage 6 (Gu et
al., 2003; Hurwitz et al., 1993; Kim et al., 2003).
In vitro model of human BBB
Given that the contact HBMEC and HA co-culture model represents one of the better in vitro
models of human BBB, this particular model was used during this study (Allen et al., 2010;
Allen and Bayraktutan, 2009; Shao and Bayraktutan, 2013; Srivastava et al., 2013). In brief,
approximately 75x103 HA were seeded onto the outer surface of Transwell inserts (polyester
membrane, 12 mm diameter, 0.4 µm pore size, Corning Costar, High Wycombe, UK) directed
upside down in a 6-well tissue culture plate and allowed to adhere to the membrane overnight.
The inserts were then inverted the correct way and placed in a sterile 12-well tissue culture
plate containing fresh medium to grow to ~80% confluence. HBMEC (~5x104 cells) were then
6added to the inner part of the membrane and both cell layers were grown to full confluence and
maintained thereafter in their respective specialised media.
BBB experiments
The integrity and function of the BBB were studied by assessments of transendothelial
electrical resistance (TEER) and paracellular flux of low (sodium fluorescein (NaF), Mw:376
Da) or high (Evan’s blue-labelled albumin (EBA), Mw:67 kDa) molecular weight permeability
markers, respectively. TEER was measured through an EVOM resistance meter and STX
electrodes (World Precision Instruments, Hertfordshire, UK). After TEER readings, the inserts
were washed thoroughly with Hank’s Balanced Salt Solution (HBSS) and transferred to fresh
12-well plates containing HBSS (2 mL). NaF (10 µg/mL) or EBA (165 µg/mL) was then added
to the luminal chambers and samples were removed every 20 min from luminal and abluminal
chambers to detect the respective concentrations of dyes by spectrophotometry (EBA, 610 nm)
or fluorometry (NaF, 440/525 nm excitation/emission). The flux across the cell-free inserts was
determined as previously described (Abdullah and Bayraktutan, 2014).
Measurement of total TNF-α levels 
    TNF-α levels were detected in cell culture supernatants using the DuoSet ELISA 
development assay kit (R&D Systems, Abingdon, UK). Briefly, supernatants collected from
endothelial cells or astrocytes, subjected to various experimental conditions, were centrifuged
at 1000 g for 10 min to remove the excess debris. Samples or standards were then added to 96-
well plates pre-coated with a capture antibody and incubated at room temperature for 2 h. The
plates were then washed with PBS containing Tween-20 (0.05%) and successively incubated
with an antibody specific for recombinant human TNF-α for 2 h at room temperature. The 
plates were then washed and incubated with HRP-linked secondary antibody (1:200) and
substrate solution for 20 min in the dark, respectively. After stopping the reactions by sulphuric
acid (2 mmol/L), the optical densities were detected by BMG LABTECH Omega plate reader
7set to 450 nm with a wavelength correction of 570 nm. The concentration of TNF-α (pg/mL) 
was calculated using the standard curves.
Measurement of total O2.- levels and NADPH Oxidase Activity
The levels of total O2.- and NADPH oxidase activity were determined as previously by
cytochrome C reduction and lucigenin chemiluminescence assays (Abdullah and Bayraktutan,
2014).
Immunoblotting
    Equal amount of total protein samples (50-65 μg) obtained from endothelial cells and were 
electrophoresed on 10% SDS-PAGE gels before transferring onto polyvinylidene fluoride
membrane (GE Healthcare, Buckinghamshire, UK). The membranes were then successively
incubated with a combination of primary antibodies specific for β-actin (mouse; cat. no. A5441; 
internal control; 1:30000; Sigma, Dorset,UK) and claudin-5 (rabbit; cat. no. ab53765; 1:500;
Abcam, Cambridge, UK) or occludin (rabbit; cat. no. sc5562; 1:650; Santa Cruz Biotech,
Heidelberg, Germany) and infrared dye-conjugated appropriate secondary antibodies (goat
anti-mouse; cat. no. 926-68020 and goat anti-rabbit; cat. no. 926-32211; 1:30000; Li-Cor
Biosciences, Cambridge, UK). The blots were visualised and analysed using the Li-Cor
Odyssey Infrared imaging system (Li-Cor Biosciences).
Gelatin zymography
    Equal amounts of culture media used to grow HBMEC or HA (~5 μL) or total cell protein 
(20-70μg/mL) were run on 10% polyacrylamide gel containing 0.1% gelatin. The gels were 
then washed in 2.5% Triton X-100 for 30 min before treating overnight with a buffer containing
50 mmol/L Tris (pH 7.5), 10 mmol/L CaCl2, 50 mmol/L NaCl and 0.05% Brij-35 (Merck
Millipore, Nottingham, UK). The gels were then stained for 2 h in 0.1% Coomassie Brilliant
Blue-G dye containing 25% methanol and 5% acetic acid and destained for a minimum of 1 h
in 50% methanol and 25% acetic acid. Bands were scanned and quantified using Li-Cor
8Odyssey Infrared imaging system and the readings were normalized to “mg protein”. The
amounts of total proteins in the samples were detected by Coomasie Plus assay kit according
to manufacturer’s instructions (Thermo Fisher Scientific, UK).
F-actin staining
Cells grown to about 80% confluence on glass coverslips were fixed and permeabilised in
4% paraformaldehyde/PBS and 0.1% Triton X-100/PBS for 15 min, respectively. The
coverslips were then blocked for 30 min with 10% BSA/PBS before staining actin filaments in
the dark with rhodamine-labelled phalloidin dye (5 U/mL, Invitrogen, Paisley, UK) for ~25
min. Slides were viewed by Zeiss Axio Observer fluorescence microscope.
TUNEL staining
TUNEL staining was performed using the DeadEnd™ colourimetric TUNEL detection kit
as per the manufacturer’s instructions (Promega, Southampton, UK). Briefly, cells cultured on
coverslips were fixed and permeabilised as above before equilibrating for 10 min with a
solution containing potassium cacodylate (200 mmol/L), Tris-HCl (25 mmol/L), dithiothreitol
(0.2 mmol/L), BSA (250 mg/L) and cobalt chloride (2.5 mmol/L). To allow end-labelling to
occur, the coverslips were then incubated for 60 min with recombinant terminal
deoxynucleotidyl transferase (rTdT) reaction mix containing equilibrium buffer (98 μL), 
biotinylated nucleotide mix (1μL) and rTDT enzyme (1μL). The reaction was terminated by 
dipping coverslips into 20X SSC buffer prior to blocking and staining them with 0.3% H2O2
and horseradish peroxidase-labelled streptavidin (500 mg/L; 1:500), respectively. TUNEL-
positive cells were then visualised by diaminobenzidine which gave the dark brown colour to
apoptotic cells. Cells were viewed under a light microscope and counted (TUNEL-positive vs
total) from 3 different fields per coverslip before calculating the mean values for these areas.
Caspase-3/7 activity
9Caspase-3/7 activities were measured by Apo-ONE homogeneous caspase-3/7 assay kit as
per manufacturer’s instructions (Promega, Southampton, UK). Briefly, cells grown to 95%
confluence in 96-well plates were exposed to experimental conditions. To initiate the reaction,
100 L of media was removed from each well and replaced by 100 L of caspase 3/7 assay
buffer, containing the non-fluorescent caspase substrate, rhodamine 110, bis-(N-CBZL-
aspartyl-L-glutamyl-L-valyl-L-aspartic acid amide; Z-DEVD-R110). Plates were then frozen
at -80°C overnight. On the following day, the plates were completely thawed on a plate shaker
before reading the fluorescence, generated by the caspase-3/7-mediated cleavage of the non-
fluorescent caspase substrate to fluorescent rhodamine-110 (excitiation/emission: 485/520
nm). Blanks were subtracted from the readings before normalising activity against “mg
protein”. Because the assay kit was found to be sensitive to the media employed, two different
controls i.e. RPMI lacking FBS, pyruvate as well as glucose and EC media were used in
measurements of caspase activity to represent controls for OGD and OGD+R phase,
respectively.
Cell Viability Assay
To detect the effects of different treatment regimens on cell viability, an aliquot of cells were
mixed with 0.1% Trypan blue for ~4 min before counting 100 cells under a light microscope
to work out the % viability rates.
Statistical Analysis
Data are presented as mean±SEM. Statistical analyses were conducted using IBM SPSS
statistics 20.0 software package. Mean values were compared by Student’s two-tailed t-test or
one-way ANOVA, where appropriate, followed by Dunnett’s post-hoc testing. P<0.05 was
considered significant.
Results
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Effects of OGD±R on TNF-α levels
    To assess whether the availability of TNF-α release is augmented by ischaemia-reperfusion 
(IR) injury in major cell lines associated with the formation and maintenance of BBB, HBMEC
and HA were first subjected to the incremental periods of OGD (30 min to 20 h). This revealed
a significant increase in both cells within 30 min of challenge that lasted up to 6 h before
declining at 12 h but remaining radically higher than controls. It is of note that the level of basal
TNF-α release remained largely unaffected in both cell types exposed to normoxic conditions 
for the indicated periods. It is also noteworthy that the level of TNF- was considerably higher
in endothelial cells compared to astrocytes. Interestingly, reintroduction of oxygen and glucose
to the cells (used to mimic reperfusion) evoked further increases in endothelial, but not
astrocytic, release of TNF-α (Figure 1A-D).  
Effect of TNF-α inhibition on BBB integrity and function 
    To assess whether TNF-α is involved in OGD±R-mediated BBB damage, a contact co-
culture model of human BBB composed of BMEC and astrocytes was exposed to 4 h of OGD
alone or followed by reperfusion in the absence or presence of an anti-TNF-α antibody. While 
OGD±R significantly perturbed barrier integrity and function, neutralisation of TNF-α 
dramatically improved both parameters as evidenced by marked increases in TEER and
concomitant decreases in NaF and EBA flux, respectively thereby proving TNF-α as an 
instrumental player in (post-)ischaemic barrier damage (Figure 2A-C). 0.2 g/ml of anti-TNF-
α antibody was used during this study due to its efficacy in normalising OGD-induced release 
of TNF-α in HBMEC (Figure 2D). Exposure of co-cultures to anti-TNF- antibody alone for
4 or 20 h did not affect paracellular permeability. Interestingly, despite causing further
reductions in TNF-α release, application of a higher concentration of anti-TNF-α antibody 
(0.5g/ml) did not further improve barrier integrity and function, indicating that normalisation
of this particular cytokine is sufficient to negate its barrier-disruptive effect (Figure 3A-C).
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Effect of TNF-α inhibition on NADPH oxidase activity and O2.- release
The basal levels of NADPH oxidase and O2.- appeared to be significantly higher (>2-fold) in
HBMEC than HA. OGD±R significantly increased NADPH oxidase activity and O2.-
generation in both cells without affecting fold-differences observed at basal levels. Again,
negation of TNF-α activity by a specific antibody substantially diminished the effects of 
OGD±R on oxidase activity and O2.- release (Figure 4A-D). Exposure of either cell line to anti-
TNF- antibody alone for 4 or 20 h did not have any impact on basal O2.- release or oxidase
activity (Figure 5A-D).
Effect of TNF-α inhibition on MMP activity 
OGD±R elevated the level of both intracellular and extracellular (secreted) pro-MMP-2 in
HBMEC. Although the expression of intracellular pro-MMP-9 stayed below the level of
detection in control cells and those subjected to OGD alone, reperfusion elevated extracellular
pro-MMP-9 expression to a level that was detectable by zymography. In contrast, OGD did not
alter intracellular and extracellular pro-MMP-2 levels in HA where reperfusion produced a
selective increase only in extracellular pro-MMP-2 while pro-MMP-9 could not be detected at
all. Inhibition of TNF-α dramatically suppressed all the aforementioned increases (Figure 6A-
C). It is of note here that no pro-MMP-2 or pro-MMP-9 expressions were detected in serum
only samples. Again, exposure of either cell line to anti-TNF- antibody alone for 4 or 20 h
did not affect basal intracellular or secreted pro-MMP-2 levels (Figure 7A-B).
Effects of TNF-α inhibition on tight junction protein expression and cytoskeleton
OGD produced significant decreases in claudin-5 and occludin protein expressions which
were further reduced by reperfusion in case of claudin-5. Neutralisation of TNF-α attenuated 
the effects of OGD±R on claudin-5 protein expression while normalising that of occludin.
Treatments with anti-TNF- antibody alone did not affect either protein expression (Figure
8A-D).
12
In concert with these changes, OGD±R evoked dramatic changes in cellular architecture as
evidenced by formation of actin stress fibres in both HBMEC and HA. While inhibition of
TNF-α effectively negated OGD±R-evoked stress fibre formation, it had no affect effect on 
cytoskeleton in normal settings (Figure 9A-B).
Effect of TNF-α inhibition on BBB-related cell apoptosis
OGD and OGD+R significantly elevated the number of apoptotic nuclei (arrows) in HBMEC
and HA where the addition of an anti-TNF- antibody effectively suppressed the rates of DNA
fragmentation. Changes in pro-apoptotic caspase-3/7 enzyme activities in HBMEC and HA
were reflective of those seen in TUNEL stainings. The magnitude of increases in these
particular enzyme activities was radically greater in HBMEC. Co-treatment of cells with the
anti-TNF-α antibody substantially suppressed the deleterious effects of ischaemic injury, 
implying that OGD±R modulates the activity of these apoptotic enzymes through TNF-α. It is 
of note that treatment with TNF- antibody was more influential in HA. Two different types
of controls had to be used in these experiments due to sensitivity of the kit used for media.
Hence, control RPMI that lacked FBS, pyruvate and glucose served as control for 4 h
OGD±anti-TNF-α antibody experiments while control ECM that possessed these served as 
control for 4 h OGD+R±anti-TNF-α antibody experiments. To reveal the actual difference in 
enzyme activity, the control readings were subtracted from the respective experimental
readings prior to graphical illustration. Treatments with anti-TNF-α antibody did not affect 
basal caspase-3/7 activities in either cell line (Figures 10A-C and 11A-C).
Discussion
Brain oedema stemming from disruption of the BBB constitutes the leading cause of
mortality within the first week after an ischaemic stroke. Accumulating evidence demonstrate
that acute inflammatory reactions accompanied by exaggerated release of pro-inflammatory
cytokines significantly contribute to the initiation and progression of this phenomenon
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(Ferrarese et al., 1999; Hosomi et al., 2005; Yang et al., 1999). Spurred on by our recent study
exhibiting an intimate correlation between the enhanced availability of TNF-α and the BBB 
damage, this study sought to reveal whether neutralisation of TNF-α may be of therapeutic 
value in attenuating the deleterious effects of IR injury on cerebral barrier (Abdullah and
Bayraktutan, 2014). Given that TNF-α is intricately involved in the pathogenesis of several 
neurological conditions, elucidation of this particular point may have far greater implications
than those are presently anticipated (Hasturk et al., 2009; Pan et al., 2006; Zaremba et al.,
2001). As cerebrovascular activity gradually deteriorates after a cerebral attack, we primarily
investigated the time course of IR-mediated TNF-α release in the most important cellular 
components of the BBB, i.e. BMEC and astrocytes, which revealed a biphasic pattern in both
cells subjected to increasing periods of OGD (0.5-20 h) alone or followed by reperfusion (20
h). Although remained significantly higher than the respective controls at all the time points
studied, the initial peak observed in TNF-α secretion at 0.5 h of insult lasted up to 6 h before 
dipping slightly but markedly at 12 h. Considering the substantially higher levels of TNF-α in 
normal and IR-induced BMEC versus the corresponding astrocytes (by ≥2.5-fold), it is safe to 
suggest that endothelium, but not astrocyte endfeet, constitutes the main vascular locus that
regulates cerebral homeostasis by synthesising and/or releasing a wide range of vasoactive
agents including bradykinin, nitric oxide and various cytokines (Abdullah and Bayraktutan,
2014; Bayraktutan, 2002). Indeed, reperfusion-mediated selective potentiation of TNF-α 
release in BMEC alone confirms endothelial dysfunction as a salient phenomenon in IR-evoked
neurovascular damage (Ferrarese et al., 1999; Hasturk et al., 2009; Yang et al., 1999) while
simultaneously indicating that astrocytes are better equipped to cope with the deleterious
effects of ischaemic injury and ensuing secondary complications like inflammation (Bresgen
et al., 2006; Chen and Swanson, 2003).
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    Having ascertained the pattern of TNF-α release in BBB-related cells, all subsequent 
experiments were performed using a clinically-relevant period of OGD (4 h) alone or followed
by reperfusion (20 h). First, using a co-culture model of human BBB comprising HBMEC and
HA, this study has verified that OGD significantly compromises barrier integrity and function
as evidenced by dramatic decreases in TEER and concurrent increases in paracellular flux of
NaF (376 Da) and EBA (67 kDa), respectively (Gibson et al., 2014; Rakkar et al., 2014). As
expected, reperfusion further augmented the extent of OGD-evoked barrier damage. Detection
of relatively lower quantities of EBA across the in vitro barrier signified that the size of some
BBB openings were not big enough to allow the passage of bigger substances. Inhibition of
TNF-α by a neutralising antibody radically attenuated, but not neutralised, the deleterious 
effects of OGD±R on barrier integrity and function similar to some previous studies reporting
a considerable improvement in neurological outcome and concurrent reductions in
haemorrhage, infarct size and cell death after ischaemia (Barone et al., 1997; Yang et al., 1999;
Yang et al., 1998; Yenari et al., 2006). Taken together these findings imply the putative
contributions of other mechanisms and possibly cytokines to IR-mediated neurovascular
damage.
Oxidative stress, characterised by an increased presence of reactive oxygen species,
especially O2.-, represents one such mechanisms. A recent study examining the specific causes
of TNF-α-induced BBB damage has in part ascribed this defect to the activation of NADPH 
oxidase and consequent production of O2.- in BMEC and astrocytes. Although levels of both
increases were dictated by the duration of incubation (2-24 h, peaking at 6 h), they appeared to
be independent of the concentration of TNF-α tested (5-20 ng/ml), indicating the inability of 
TNF-α to exert further barrier damage beyond a certain threshold (Abdullah and Bayraktutan, 
2014). Considering the abundant release of TNF-α during the first 6 h of ischaemic insult, it is 
inevitable that oxidative stress plays a central role in the early phases of ischaemic stroke.
15
Indeed, OGD±R-mediated increases in both endothelial and astrocytic NADPH oxidase
activity and O2.- production corroborated this assumption. Similar to previous studies, the level
of increases induced by reperfusion in oxidase activity and O2.- production appeared to be small
but significant in both cell types (Abdullah and Bayraktutan, 2014; Gibson et al., 2014). Here,
measurement of significantly greater levels of oxidase activity and O2.- in BMEC has reinforced
the decisive role of endothelial dysfunction in vasculopathies while discovery of substantially
diminished oxidase activity in astrocytes has provided an additional explanation for their
resistance to oxidative stress which had previously been attributed to the existence of strong
inherent antioxidant capacity in them (Abdullah and Bayraktutan, 2014; Bresgen et al., 2006;
Chen and Swanson, 2003). NADPH oxidase is regarded as the main source of O2.- in BBB-
related cells, neurons, leukocytes and post-ischaemic brain. Suppression of its activity by
structurally distinct inhibitors like DPI and apocynin as well as knockout of its membrane-
bound or cytosolic subunits e.g. gp91-phox and p47-phox in mice has been coupled to the
effective maintenance of barrier integrity and neuronal viability following an ischaemic
episode (Abdullah and Bayraktutan, 2014; Rakkar et al., 2014; Suh et al., 2007). In the current
study, inhibition of oxidase activity and O2.- generation in BMEC and astrocytes by a TNF-α 
IgG demonstrates that NADPH oxidase acts downstream to TNF-α in ischaemic settings and 
is manipulated by it to disrupt BBB. Manipulation of this particular oxidase by another
inflammatory cytokine i.e. IL-1β has also been reported in pial arteries of a stroke model where 
the enhanced release of bradykinin during cerebral ischaemia caused an increase in IL-1β levels 
which in turn activated NADPH oxidase to perturb BBB (Woodfin et al., 2011).
Activation of MMPs that digest various components of the basement membrane, notably
collagen IV, laminin and fibronectin may also contribute to OGD±R/TNF-α pathway-evoked 
cerebral barrier disruption. To date, many members of MMP family of endopeptidases sharing
similar primary structure and requiring Zn+2 for their catalytic activity have been identified.
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Amongst these, MMP-2, MMP-9 and their inactive proforms represent the most studied
isoforms that have closer relevance to ischaemic cerebral injury (Nagase et al., 1997; del Zoppo
et al., 2007). Since active forms of MMP-2 and MMP-9 are considerably less stable than their
inactive proforms and isolation, handling and the type of cells significantly affect their
detection in active form (Fujimura et al., 1999; Romanic et al., 1998) , the levels of pro-MMPs
were studied in the present study which revealed substantial increases in intracellular and
extracellular levels of endothelial pro-MMP-2, suggesting the potential involvement of its
active form in OGD±R/TNF-α pathway-evoked cerebral barrier disruption. Although a similar 
increase was also recorded in astrocytes, this appeared to be confined to the extracellular
isoform during the reperfusion phase. In contrast, despite selectively detecting extracellular
pro-MMP-9 in BMEC during reperfusion phase, neither active nor pro-MMP-9 could be
detected in astrocytes. Collectively, these data show endothelium as the main source of MMPs
in ischaemic conditions and add weight to the notion that astrocytes can only generate pro-
MMP-9 under certain experimental conditions (Massengale et al., 2002). Similarly, several
previous studies have also attributed increases in infarct volume, BBB permeability and
haemorrhagic transformation to ischaemic injury-mediated overexpression of (pro)-MMP-2/9
(Bauer et al., 2010; Fujimura et al., 1999; Romanic et al., 1998; Heo et al., 1999). Normalisation
or attenuation of pro-MMP-2 (and where detectable pro-MMP-9) levels by an anti-TNF-α 
antibody during OGD and OGD+R, respectively indicate that neutralisation of TNF-α exerts 
better protection during the early stages of ischaemic injury while other elements become more
prominent during the later phases of injury. Indeed, normalisation of MMP activities by
apocynin and DPI in BMEC exposed to TNF-α (5 ng/ml) propose NADPH oxidase and O2.- as
important regulators of MMP activity. However, reduction in basal lamina protein loss
resulting from the successive suppression of TNF-α and MMP-9 activity was important in 
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restoring BBB integrity and function in rodents subjected to peripheral thermal injury (Reyes
et al., 2009).
In addition to enzymatic digestion of basement membrane components, the changes in
cellular architecture may also accentuate the permeability of cerebral barrier. Experiments
focusing on the potential structural alterations in microfilaments, a pivotal component of
cytoskeleton, revealed that both BMEC and astrocytes cultured in normal conditions displayed
a cortical actin distribution which facilitates the formation of junctional complexes by
anchoring integral membrane proteins occludin and claudin-5 with the membrane-associated
proteins ZO-1 and ZO-2 to prevent paracellular flux. In contrast, cells exposed to OGD±R
underwent a moderate shrinkage and developed thick stress fibres that traversed the cells and
produced a tensile centripetal force to pull junctional proteins inwards to create intercellular
openings. Besides maintaining appropriate cytoskeletal structure, actin also regulates the
growth; Ca2+ uptake, release and signaling; Cl– conductance and glutamate uptake in astrocytes
(Cotrina et al., 1998; Zigmond., 1996; Duan et al., 1999; Sergeeva et al., 2000). Considering
the pivotal roles played by astrocytes to maintain physiological pH in the extracellular space,
supply neurons with nutrients, remove metabolic byproducts and regulate synaptic
development and strength (Nedergaard et al., 2003; Haydon., 2001), it is safe to suggest that
ischaemia-induced neuroinflammation and ensuing actin filament reorganisation may elicit
astrocyte and BBB dysfunction. Indeed, recent studies coupling reorganisation of
microfilaments in astrocyte networks to significant alterations in Ca2+ signalling systems,Na+/K+-ATPase and glutamate transporters and those showing increased release of pro-inflammatory cytokines in a model of lipopolysaccharide-induced neuroinflammation fully
support this notion (reviewed by Hansson., 2015).
Other than dislocating TJ proteins, OGD±R also caused significant reductions in TJ protein
expressions. While both OGD and OGD+R diminished occludin levels in equal measures, the
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decrease in claudin-5 levels appeared to be more prominent after the onset of reperfusion.
Similar decreases in these protein levels were also reported in experimental stroke models (Liu
et al., 2012; McColl et al., 2008; Yang et al., 2006). As the injection of TNF-α caused 
significant reductions in occludin and claudin-1 mRNA and protein levels in the intestines of
a mouse model of fulminant hepatic failure and inhibition of TNF-α decreased intestinal 
permeability by stemming claudin-1 and occludin downregulation (Li et al., 2012), we assessed
the impact of a TNF-α neutralising antibody on cytoskeletal organization and TJ protein 
expressions. In concert with its effects on the BBB permeability, the inhibition of TNF-α 
maintained normal endothelial cell and astrocyte morphology by reducing IR-evoked stress
fibre formation while significantly improving (claudin-5) or normalising (occludin) TJ protein
expressions.
Increasing evidence report that apoptosis of BMEC and astrocytes exacerbates the extent of
ischaemic injury by compromising the formation of TJs and microvascular integrity through a
range of mechanisms including elevated availability of ROS, Bax protein overexpression,
mitochondrial dysfunction and upregulation of caspase-3 and other caspase family members
(Giffard and Swanson, 2005; Kontos, 2001; Krupinski et al., 2000; Scarabelli et al., 2002).
However, since little is known about the exact molecular mechanism of apoptosis in vascular
tissue after IR, the present study investigated the impact of OGD±R on HBMEC and HA
apoptosis and searched whether TNF-α is involved in this phenomenon. Consequently, it has 
been shown that OGD±R significantly increases pro-apoptotic caspase-3/7 activities and DNA
fragmentation rates in both BMEC and astrocytes. Although detection of higher rates of
apoptosis after reperfusion suggests the idea that oxidative stress contributes to this defect, anti-
TNF-α antibody-induced substantial decreases in both parameters proved this particular 
cytokine as a crucial regulator of vascular cell death after OGD±R.
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    In conclusion, the current results reveal that exaggerated release of TNF-α during IR injury 
promotes cerebrovascular damage through concurrent regulations of oxidative stress, MMP
activity and BBB-related cell apoptosis. Effective attenuations of these parameters by a TNF-
α antibody coupled with improvements in BBB integrity and function strongly suggest that 
targeting of TNF-α may be of therapeutic value after an ischaemic stroke. 
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Figure Legends
Figure 1. The effects of OGD±R on TNF-α levels. HBMEC and HA were exposed to OGD 
alone for a period of 30 min, 1, 2, 4, 6, 12 and 20 h or followed by 20 h of reperfusion. Both
OGD and OGD+R significantly increased TNF-α levels in both HBMEC (A, C) and HA (B,
D) as early as 30 min lasting up to 20 h compared with untreated groups. Data are expressed
as mean±SEM from 10 different experiments. *p<0.05 vs control, †p<0.05 vs 30 min treatment
group, #p<0.05 vs 1 h treatment group.
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Figure 2. The effects of OGD±R on BBB integrity and function. HBMEC-HA co-cultures
were exposed to 4 h of OGD alone or followed by 20 h of reperfusion (OGD+R) in the absence
or presence of an inhibitor for TNF-α, an anti-TNF-α antibody. While OGD±R significantly 
impaired BBB integrity and function, co-treatments with TNF-α antibody attenuated their 
impact on BBB integrity (A) as well as NaF (B) and EBA (C) flux. Data are expressed as
mean±SEM from 8 different experiments. *p<0.05 vs control, †p<0.05 vs OGD, #p<0.05 vs
OGD+anti-TNF-α antibody, ‡p<0.05 vs OGD+R.
Figure 3. The effect TNF-α inhibition on BBB integrity and function. Exposure of HBMEC-
HA co-cultures to two different concentrations of an anti-TNF-α antibody alone for 4 and/or 
20 h had no effect on BBB integrity (A) as well as NaF (B) and EBA (C) flux. Data are
expressed as mean±SEM from 6 different experiments.
Figure 4. The effects of OGD±R on total O2.- production and NADPH oxidase activity.
HBMEC and HA were exposed to 4 h of OGD alone or followed by 20 h of reperfusion
(OGD+R) in the absence or presence of an anti-TNF-α antibody. Compared to controls, both 
OGD and OGD+R enhanced O2.- release and NADPH oxidase activity in HBMEC (A, C) and
HA (B, D) that were markedly reduced by treatments with an anti-TNF-α antibody. Data are 
expressed as mean±SEM from 12 different experiments. *p<0.05 vs control, †p<0.05 vs OGD,
#p<0.05 vs OGD+anti-TNF-α antibody, ‡p<0.05 vs OGD+R.
Figure 5. The effect TNF-α inhibition on total O2.- production and NADPH oxidase activity.
Incubations with anti-TNF- antibody (0.2 g/ml) alone for 4 or 20 h did not alter O2.-
production and NADPH oxidase activity in HBMEC (A, C) or HA (B, D). Data are expressed
as mean±SEM from 4 different experiments.
Figure 6. The effects of OGD±R on MMP activities. Representative gelatin zymographies
showing the impact of 4 h of OGD alone or followed by 20 h of reperfusion (OGD+R) in the
absence or presence of an anti-TNF-α antibody on MMP-2 and MMP-9 activities in HBMEC 
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(A, C) and HA (B). OGD±R caused significant increases in intracellular and extracellular
MMP-2 activity in HBMEC while an increase is only detected in extracellular MMP-2 during
reperfusion phase in HA. OGD+R but not OGD alone caused a significant increase in
extracellular MMP-9 in HBMEC. Treatments with TNF-α antibody reduced all the observed 
increases in MMP-2 and MMP-9 activities. Data are expressed as mean±SEM from 7 different
experiments. *p<0.05 vs control, †p<0.05 vs OGD, #p<0.05 vs OGD+anti-TNF-α antibody, 
‡p<0.05 vs OGD+R.
Figure 7. The effect TNF-α inhibition on MMP activities. Treatment with an anti-TNF-
antibody (0.2 g/ml) alone for 4 or 20 h did not affect intracellular or secreted pro-MMP-2
expression in HBMEC (A) and HA (B). Data are expressed as mean±SEM from 4 different
experiments.
Figure 8. The effects of OGD±R and TNF-α inhibition on TJ protein expressions.  
Representative Western blots and densitometric analyses of claudin-5 (A) and occludin (B) in
HBMEC subjected to 4 h of OGD alone or followed by 20 h of reperfusion (OGD+R) in the
absence and presence of an anti-TNF-α antibody. OGD±R caused significant reductions in both 
claudin-5 and occludin protein levels in HBMEC where inhibition of TNF-α antibody 
attenuated the level of decreases. Treatment with an anti-TNF- antibody (0.2 g/ml) alone
for 4 or 20 h had no effect on either protein expression (C, D). Data are expressed as
mean±SEM from ≥4 different experiments. *p<0.05 vs control, †p<0.05 vs OGD, #p<0.05 vs
OGD+anti-TNF-α antibody, ‡p<0.05 vs OGD+R.
Figure 9. The effects of OGD±R and TNF-α inhibition on cytoskeletal organisation. F-actin 
staining revealing cytoskeletal formation was performed with rhodamine-labelled phalloidin
dye in HBMEC (A) and HA (B) subjected to an anti-TNF- antibody (0.2 g/ml) alone or
OGD±R in the absence and presence of an inhibitor for TNF-α. OGD±R induced actin stress 
fibres formation in both cells (indicated by arrows) which were attenuated by anti-TNF-α 
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antibody. Treatment with the anti-TNF- antibody alone for 4 or 20 h did not influence actin
filament formation. Scale bars = 20μm. Data are expressed as mean±SEM from 8 different 
experiments.
Figure 10. The effects of OGD±R and TNF-α inhibition on apoptosis and caspase-3/7 activity 
in HBMEC. 4 h of OGD alone or followed by 20 h of reperfusion (OGD+R) increased DNA
fragmentation rates, an indicator of apoptosis (A) and caspase-3/7 activities (B). Inhibition of
TNF- by an antibody attenuated OGD±R-evoked changes in both parameters without
affecting their basal levels (C). Representative TUNEL staining showing apoptotic cells
indicated by arrows in HBMEC Scale bars = 20μm. Data are expressed as mean±SEM from 8 
different experiments. *p<0.05 vs OGD, †p<0.05 vs OGD+R.
Figure 11. The effects of OGD±R and TNF-α inhibition on apoptosis and caspase-3/7 activity 
in HA. 4 h of OGD alone or followed by 20 h of reperfusion (OGD+R) increased DNA
fragmentation rates, an indicator of apoptosis (A) and caspase-3/7 activities (B). Inhibition of
TNF- by an antibody attenuated OGD±R-evoked changes in both parameters without
affecting their basal levels (C). Representative TUNEL staining showing apoptotic cells
indicated by arrows in HBMEC Scale bars = 20μm. Data are expressed as mean±SEM from 8 
different experiments. *p<0.05 vs OGD, †p<0.05 vs OGD+R.
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